Literature DB >> 23158177

Utility of oral nicardipine and magnesium sulfate infusion during preparation and resection of pheochromocytomas.

Hasan K Siddiqi1, Hui-yu Yang, Amanda M Laird, Amy C Fox, Gerard M Doherty, Barbra S Miller, Paul G Gauger.   

Abstract

BACKGROUND: Calcium channel blockade with nicardipine (NC) is an alternative to phenoxybenzamine (PB) preparation for resection of a pheochromocytoma. Intraoperative magnesium sulfate infusion (+MgSO(4)) is often used for its cardiovascular stabilizing properties. We hypothesized that preparation with NC would be similar clinically to PB for resection of a pheochromocytoma, and MgSO(4) infusion would not affect intraoperative stability.
METHODS: This retrospective review included 64 patients undergoing resections of a pheochromocytoma from 2003 to 2011. PB or NC was used preoperatively, with MgSO(4) use distributed equally in the population. Pre-, intra-, and postoperative hemodynamics and outcomes were compared.
RESULTS: There was no difference in NC (n = 7) versus PB (n = 57) or +MgSO(4) (n = 33) versus -MgSO(4) (n = 31) groups for demographics with the exception of age. The NC group had smaller median tumor size and lesser plasma baseline levels of normetanephrine than the PB group, but subgroup analysis of all neoplasms <3.0 cm revealed no differences. Pre-, intra- and postoperative hemodynamic stability and outcomes were similar for NC versus PB analyses as well as the +MgSO(4) versus -MgSO(4) groups.
CONCLUSION: NC use may be an equivalent alternative to PB in preoperative preparation, especially for smaller pheochromocytomas. Intraoperative MgSO(4) use does not seem to have a substantive effect on hemodynamic stability.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23158177     DOI: 10.1016/j.surg.2012.08.023

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  10 in total

1.  Predictive factors for postoperative morbidity after laparoscopic adrenalectomy for pheochromocytoma: a multicenter retrospective analysis in 225 patients.

Authors:  Laurent Brunaud; Phi-Linh Nguyen-Thi; Eric Mirallie; Marco Raffaelli; Menno Vriens; Pierre-Etienne Theveniaud; Myriam Boutami; Brendan M Finnerty; Wessel M C M Vorselaars; Inne Borel Rinkes; Rocco Bellantone; Celestino Lombardi; Thomas Fahey; Rasa Zarnegar; Laurent Bresler
Journal:  Surg Endosc       Date:  2015-06-20       Impact factor: 4.584

Review 2.  Diagnosis and management of pheochromocytoma: a practical guide to clinicians.

Authors:  Joseph M Pappachan; Diana Raskauskiene; Rajagopalan Sriraman; Mahamood Edavalath; Fahmy W Hanna
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

Review 3.  Hypertension in Pheochromocytoma and Paraganglioma: Evaluation and Management in Pediatric Patients.

Authors:  Meredith L Seamon; Ikuyo Yamaguchi
Journal:  Curr Hypertens Rep       Date:  2021-05-27       Impact factor: 5.369

4.  Are patients with hormonally functional phaeochromocytoma and paraganglioma initially receiving a proper adrenoceptor blockade? A retrospective cohort study.

Authors:  Henrique Vara Luiz; Mary Jane Tanchee; Maria G Pavlatou; Run Yu; Joan Nambuba; Katherine Wolf; Tamara Prodanov; Robert Wesley; Karen Adams; Tito Fojo; Karel Pacak
Journal:  Clin Endocrinol (Oxf)       Date:  2016-04-15       Impact factor: 3.478

Review 5.  Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features.

Authors:  Alberto Mazza; Michela Armigliato; Maria Cristina Marzola; Laura Schiavon; Domenico Montemurro; Giorgio Vescovo; Marco Zuin; Sotirios Chondrogiannis; Roberta Ravenni; Giuseppe Opocher; Patrick M Colletti; Domenico Rubello
Journal:  Endocrine       Date:  2013-07-02       Impact factor: 3.633

Review 6.  Update on Modern Management of Pheochromocytoma and Paraganglioma.

Authors:  Jacques W M Lenders; Graeme Eisenhofer
Journal:  Endocrinol Metab (Seoul)       Date:  2017-06

Review 7.  Perioperative Management of Pheochromocytomas and Sympathetic Paragangliomas.

Authors:  Gustavo F C Fagundes; Madson Q Almeida
Journal:  J Endocr Soc       Date:  2022-01-14

8.  Risk factors for prolonged hypotension in patients with pheochromocytoma undergoing laparoscopic adrenalectomy: a single-center retrospective study.

Authors:  Shubin Wu; Weiyun Chen; Le Shen; Li Xu; Afang Zhu; Yuguang Huang
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

9.  Intraoperative hypotension is associated with increased postoperative complications in patients undergoing surgery for pheochromocytoma-paraganglioma: a retrospective cohort study.

Authors:  Nan Li; Hao Kong; Shuang-Ling Li; Sai-Nan Zhu; Zheng Zhang; Dong-Xin Wang
Journal:  BMC Anesthesiol       Date:  2020-06-12       Impact factor: 2.217

Review 10.  Preoperative Management of Pheochromocytoma and Paraganglioma.

Authors:  Fang Fang; Li Ding; Qing He; Ming Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-29       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.